Differential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy-Reference-Cited by-同舟云学术

Differential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy

Published:2016-02-03 Issue:7 Volume:30 Page:1606-1609
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Chen Z,Cortes J E,Jorgensen J L,Wang W,Yin C C,You M J,Jabbour E,Kantarjian H M,Medeiros L J,Hu S

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu20166.pdf

Reference15 articles.

1. Luatti S, Castagnetti F, Marzocchi G, Baldazzi C, Gugliotta G, Iacobucci I et al. Additional chromosomal abnormalities in Philadelphia-positive clone: Adverse prognostic influence on frontline imatinib therapy: A GIMEMA Working Party on CML analysis. Blood 2012; 120: 761–767.

2. Fabarius A, Leitner A, Hochhaus A, Müller MC, Hanfstein B, Haferlach C et al. Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: Long-term observation of 1151 patients from the randomized CML Study IV. Blood 2011; 118: 6760–6768.

3. Johansson B, Fioretos T, Mitelman F . Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematol 2002; 107: 76–94.

4. Haaß W, Kleiner H, Weiß C, Haferlach C, Schlegelberger B, Müller MC et al. Clonal evolution and blast crisis correlate with enhanced proteolytic activity of separase in BCR-ABL b3a2 fusion type CML under imatinib therapy. PloS One 2015; 10: e0129648.

5. Gambacorti-Passerini C, Piazza R . How I treat newly diagnosed chronic myeloid leukemia in 2015. Am J Hematol 2015; 90: 156–161.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Factors and Clinical Outcomes in Patients with Blast Phase Chronic Myeloid Leukemia;Clinical Laboratory;2024

2. Control of Ph+ and additional chromosomal abnormalities in chronic myeloid leukemia by tyrosine kinase inhibitors;Medical Oncology;2023-07-13

3. Blast phase of chronic myeloid leukemia with concurrent BCR::ABL1 and SET::NUP214 : A report of two cases;Molecular Carcinogenesis;2022-11-02

4. Unusual B-Lymphoid Blastic Crisis as Initial Presentation of Chronic Myeloid Leukemia Imposes Diagnostic Challenges;Case Reports in Hematology;2022-06-25

5. Chromosomal Instability in Chronic Myeloid Leukemia: Mechanistic Insights and Effects;Cancers;2022-05-21